Because an autocrine circuit cell contains both the CAR and synNotch→IL-2 circuit, it has the capability to become both a preferred IL-2 responder (via T cell activation) and strong IL-2 producer (via synNotch activation) within a tumor. This evidence concerns the gene IL2 and neoplasm.